Burning Rock Biotech (BNR) Payables (2020 - 2025)
Historic Payables for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $4.8 million.
- Burning Rock Biotech's Payables rose 3181.82% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 3181.82%. This contributed to the annual value of $4.7 million for FY2024, which is 7338.74% up from last year.
- Latest data reveals that Burning Rock Biotech reported Payables of $4.8 million as of Q3 2025, which was up 3181.82% from $4.6 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Payables high stood at $28.1 million for Q4 2021, and its period low was $2.7 million during Q4 2023.
- Moreover, its 5-year median value for Payables was $4.8 million (2025), whereas its average is $7.2 million.
- In the last 5 years, Burning Rock Biotech's Payables surged by 32743.61% in 2021 and then tumbled by 7685.8% in 2023.
- Burning Rock Biotech's Payables (Quarter) stood at $28.1 million in 2021, then plummeted by 72.76% to $7.6 million in 2022, then plummeted by 64.53% to $2.7 million in 2023, then soared by 73.39% to $4.7 million in 2024, then grew by 2.95% to $4.8 million in 2025.
- Its Payables was $4.8 million in Q3 2025, compared to $4.6 million in Q2 2025 and $5.0 million in Q1 2025.